ライフサイエンスコーパス: receptor

1 tation assay to screen against this chimeric receptor.

2 ing of the human G protein-coupled adenosine receptor.

3 tors stimulates targeted modification of the receptor.

4 neage III KIR, likely encoding a C1-specific receptor.

5 synaptic TRPV1 channels by alpha2 adrenergic receptors.

6 ell; it also regulates the activity of these receptors.

7 t lacks the ability to interact with Fcgamma receptors.

8 data suggest the importance of delta-opioid receptors.

9 r effectively blocking both AMPA and kainate receptors.

10 od via downstream communication to mPFC NMDA receptors.

11 y a sustained coexpression of PD-1 and TIGIT receptors.

12 or (BCR), Fc receptors (FcRs), and toll-like receptors.

13 ing hypothalamic peptide orthologs and their receptors.

14 t off-rate antagonist of NMDA-type glutamate receptors.

15 he nervous and immune systems using distinct receptors.

16 an potentially inhibit both AMPA and kainate receptors.

17 eterotrimeric G-protein by G-protein coupled receptors.

18 IRI through bone marrow-derived adenosine 2a receptors.

19 2+) channels and synaptically activated NMDA receptors.

20 as hetero-oligomeric alpha1beta2gamma2 GABAA receptors.

21 o be required for binding of multiple glycan receptors.

22 y-5-methylisoxazole-4-proprionic acid (AMPA) receptors.

23 exes by mediating RIP1 dissociation from TNF receptor 1.

24 NADA is also an agonist of cannabinoid receptors 1 and 2.

25 However, decreasing sulfonylurea receptor-1 trajectories between 48 and 72 hours were sig

26 Platelet C-type lectin-like receptor 2 (CLEC-2) is known to maintain the physiologic

27 ion with relaxin/insulin-like family peptide receptor 2 (RXFP2).

28 Protease-activated receptor 2 activates airway apical membrane chloride per

29 biophysically on the metabotropic glutamate receptor 2 homodimer.

30 obilized upon inflammation in a CC-chemokine receptor 2-dependent manner, and the nonclassical blood

31 that hRetn binds the LPS receptor Toll-like receptor 4 (TLR4) through its N terminal and modulates S

32 Drugs targeting metabotropic glutamate receptor 5 (mGluR5) have therapeutic potential in autism

33 IFNgamma signals through the IFNgamma receptor, a protein complex that mediates downstream sig

34 d 25 as a potent and selective A2A adenosine receptor (A2AAdoR) antagonist with reasonable ADME and p

35 The adenosine A2A receptor (A2AR) has long been implicated in cardiovascul

36 g vs. hyperpolarizing) of postsynaptic GABAA receptor actions.

37 ative Ly6C(low) Mos/Mps, indicating that Ep3 receptor activation may be a promising therapeutic targe

38 TLR2 agonists required pannexin-1 and P2X7 receptor activation to stimulate IL-1beta release.

39 lly observed and appears to be essential for receptor activation.

40 that up-regulates Id2, the repressor of the receptor activator of nuclear factor-kappaB ligand-media

41 ciated molecular pattern receptors, cytokine receptors, adipokine receptors, and hormones.

42 ys statistical resampling to measure the Eph receptor aggregation distribution within each pixel of a

43 -4 (EX-4), a glucagon-like peptide-1 (GLP-1) receptor agonist, has been shown to reduce food intake a

44 Muscarinic receptor agonists are characterized by apparently strict

45 enobiotic activation of the aryl hydrocarbon receptor (AHR) by 2,3,7,8-tetrachlorodibenzo-p-dioxin (T

46 Estrogen receptor alpha (ERalpha) regulates gene transcription th

47 we show that platelet-derived growth factor receptor alpha (PDGFRalpha) and its ligand platelet-deri

48 e report that platelet-derived growth factor receptor alpha (PDGFRalpha) positive ( + ) cells accumul

49 DF15 binds with high affinity to GDNF family receptor alpha-like (GFRAL), a distant relative of recep

50 Here we report that GDNF-family receptor alpha-like (GFRAL), an orphan member of the GFR

51 also demonstrate that the PML retinoic acid receptor-alpha (PML-RARalpha) oncofusion protein, which

52 Y POINTS: The AMPA-type ionotropic glutamate receptors (AMPARs) mediate the majority of excitatory sy

53 ediated by AMPA-subtype ionotropic glutamate receptors (AMPARs).

54 ough heterologously expressed glucocorticoid receptor and degradation of a permanently misfolded prot

55 their functional roles in engaging the host receptor and in mediating membrane fusion, respectively.

56 xy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and mammalian target of rapamycin (mTOR) signal

57 mary epithelial cells (MECs) via its cognate receptor and the downstream JAK2-STAT5a signalling pathw

58 the plasma membrane that segregate membrane receptors and affect membrane curvature and vesicle form

59 ence toward alphaVbeta3 (using both isolated receptors and alphaVbeta3-overexpressing endothelial pro

60 of glutamatergic N-methyl-D-aspartate (NMDA) receptors and decreased expression of alpha-amino-3-hydr

61 by their activation of different type I BMP receptors and distinct modulations of the cell cycle.

62 tor systems, notably including growth factor receptors and G protein-coupled receptors, control myeli

63 that binds with high affinity to GPIIb/IIIa receptors and has suitable pharmacokinetic properties to

64 emonstrate that clemizole binds to serotonin receptors and its antiepileptic activity can be mimicked

65 also participates in the induction of IL-13 receptors and miR-126a expressed on/in the MDSCs.

66 ich are internalized by binding to scavenger receptors and subsequently escape the early endosome thr

67 Using siRNAs to type I and II BMP receptors and the signaling intermediaries (Smads), we d

68 ern receptors, cytokine receptors, adipokine receptors, and hormones.

69 beta-adrenergic receptor antagonism after experimental stroke prevents l

70 terneurons or locally introducing DA or GABA receptor antagonists alters kinship preference.

71 dicates that radiolabeled somatostatin (sst) receptor antagonists perform better than agonists in det

72 n the presence of anti-angiotensin II type 1 receptor antibody (AT1R-Ab) and anti-endothelial cell an

73 and TSPX competitively bind to the androgen receptor (AR) and AR variants, such as AR-V7, at their c

74 In the striatum, where D2 receptors are abundant, antipsychotic medications may af

75 ring this process, key polarity proteins and receptors are recruited to the surface of mammary epithe

76 e examined the role of tumor necrosis factor receptor-associated factor 2 (Traf2) in regulating myoca

77 ontrolling the precise localization of these receptors at specific region of the cell; it also regula

78 cooperativity, renders our new cuboctahedral receptor attractive for incorporation into systems with

79 f p110alpha-p85 heterodimers bound to active receptors, augmenting PI3K signaling and oncogenic trans

80 splice donor site mutation in the scavenger receptor B1 (SCARB1; also known as SR-B1) gene.

81 fied an immune cell-specific, co-stimulatory receptor B7.2 (CD86) as a co-receptor of lymphotropic HC

82 regulate signaling downstream of the B-cell receptor (BCR), Fc receptors (FcRs), and toll-like recep

83 s the activity of the pivotal B-cell antigen receptor (BCR)-proximal effector spleen tyrosine kinase

84 f B-lineage transcription factors and B cell receptor (BCR)/pre-BCR-signaling genes.

85 detected in estrogen receptor, progesterone receptor, beta-catenin, or vimentin expression between p

86 e encephalitic-specific motifs implicated in receptor binding.

87 bly located on the apex of the molecule; the receptor-binding mode might be different from that of re

88 RBDs mutated in multiple key residues in the receptor-binding motif (RBM) of RBD and demonstrated the

89 Nonetheless, the evolution of the receptor-binding site and the stem region on HA is sever

90 long-term bioluminescence recordings, GABAA receptor blockade desynchronized the Fbxl3(+/+) but not

91 Beta-receptor blockade does not alter the tachycardia phase t

92 PD-1 inhibitory receptor blockade partially reversed T cell unresponsive

93 l study indicates that use of angiotensin II receptor blockers might be associated with a lesser risk

94 ,637 controls, current use of angiotensin II receptor blockers was followed by a decreased risk of ac

95 d by their ability to couple to dopamine D1R receptors by real-time bioluminescence resonance energy

96 r both the insulin receptor (IR) and mannose receptor C-type 1 (MR), which functions to clear endogen

97 51) transgenic zebrafish that uses a mannose receptor, C type 1 (mrc1a) promoter to drive strong EGFP

98 lement anaphylatoxin C5a, which acts via two receptors, C5aR1 and C5aR2, expressed on immune and bone

99 er understand how loss of D2-family dopamine receptors can ameliorate tau toxicity, we screened a col

100 o low pH and was proposed to be a sour taste receptor candidate.

101 neurons (CCK-INTs), a prominent CB subtype-1 receptor (CB1R) expressing neuronal population throughou

102 Activating the renal cannabinoid-1 receptor (CB1R) induces nephropathy, whereas CB1R blocka

103 identify five factors, including the HIV co-receptors CD4 and CCR5, that are required for HIV infect

104 Here, we show that the C-type lectin receptor CD69 controls tTreg cell development and periph

105 cles onto spatially segregated post-synaptic receptors clusters, but a pre-synaptic segregation of ch

106 that mediates IL-37 binding to the TGF-beta receptor complex.

107 tudy found that ACh stimulation of nicotinic receptors comprised of alpha4 and beta2 subunits (alpha4

108 growth response 3 (EGR3) is increased in D1 receptor containing MSNs of mice susceptible to social d

109 rowth factor receptors and G protein-coupled receptors, control myelination.

110 ementary motifs at cell surface resulting in receptor crosslinking and apoptosis induction.

111 ity, response to colony-stimulating factor 1 receptor (CSF-1R) blockade and nanoparticle-based drug d

112 Comparing the early receptor current amplitude and action spectra between WT

113 ound that inhibitory odors triggered outward receptor currents by reducing the constitutive activitie

114 ession of the Th1-characteristic trafficking receptor CXCR3, which correlated with significant impair

115 We found that two chemokine receptors, CXCR3 and CCR10, are upregulated on HSV-speci

116 al adhesion kinase-1 (FAK) and the chemokine receptor CXCR4 promote epithelial repair mechanisms.

117 The recently discovered chemokine receptor CXCR7 and its ligand stromal cell-derived facto

118 ptors, pathogen-associated molecular pattern receptors, cytokine receptors, adipokine receptors, and

119 (mGluRI) activation, facilitates D1 dopamine receptor (D1R) expression, and ensures long-term synapti

120 nditional knock-out of Cav1.2 in dopamine D1 receptor (D1R)-expressing cells resulted in attenuation

121 eroarylhomopiperazines with high dopamine D2 receptor (D2R) affinity.

122 e-blind, placebo-controlled pharmacology [D2 receptor (D2R) antagonist amisulpride] in humans with re

123 the expression of the Netrin-1 guidance cue receptor DCC (deleted in colorectal cancer) appear to co

124 Growth hormone receptor deficiency (GHRD) results in short stature, enh

125 therosclerosis-prone low-density lipoprotein receptor deficient (Ldlr(-/-)) mice.

126 the psychiatric risk gene TCF4 enhances NMDA receptor-dependent early network oscillations.

127 ic constraint that is mediated by muscarinic receptor-dependent regulation of mitochondrial function

128 Paired immune receptors display near-identical extracellular ligand-bi

129 To understand how these receptors distinguish ACh and Cho, we used single-channe

130 Activation of the delta-opioid receptor (DOR) produces similar analgesia with reduced s

131 t the role of vacuole-related proteins in BR receptor dynamics and BR responses remains elusive.

132 SM proteins [4, 5], ion channels [6, 7], and receptors (e.g., [8]).

133 e sequence of gene activation/expression and receptor editing of these isotypes have not been studied

134 Current anti-epidermal growth factor receptor (EGFR) therapy for oral cancer does not provide

135 late the function of epidermal growth factor receptor (EGFR), the effect of protein methylation on it

136 aloglycoprotein receptor, or the transferrin receptor eliminates intramembrane proteolysis, as does l

137 ity of breast cancers expresses the estrogen receptor (ER(+)) and is treated with anti-estrogen thera

138 er expression of the IL-4Ralpha and estrogen receptor (ER) alpha compared with macrophages from male

139 ularly against tumors driven by the estrogen receptor (ER).

140 oding variants in the gene TREM2 (triggering receptor expressed on myeloid cells 2).

141 studies and functional assays that use human receptors expressed in Chinese hamster ovary cells demon

142 Correlations between P2 nucleotide receptor expression and hCPC growth kinetics revealed do

143 ly relevant Ezh2 inhibitors restore androgen receptor expression and sensitivity to antiandrogen ther

144 receptor family serve as pattern recognition receptors facilitating pathogen uptake, antigen processi

145 Many members of the C-type lectin receptor family serve as pattern recognition receptors f

146 instructing T reg formation via neonatal Fc receptor (FcRn)-mediated transfer and uptake of allergen

147 downstream of the B-cell receptor (BCR), Fc receptors (FcRs), and toll-like receptors.

148 Here, we investigated the role of the receptor for advanced glycation end products (RAGE) in n

149 of the GFR-alpha family, is a high-affinity receptor for GDF15.

150 ane glycoprotein dystroglycan functions as a receptor for multiple extracellular matrix proteins and

151 To identify the endogenous receptor for PGE2-G, we performed a subtractive screenin

152 GPR151 is a G-protein coupled receptor for which the endogenous ligand remains unknown

153 or alpha-like (GFRAL), a distant relative of receptors for a distinct class of the TGF-beta superfami

154 Toll-like receptors (TLRs) are innate immune receptors for sensing microbial molecules and damage-ass

155 precise mechanism by which the bacterial SRP receptor, FtsY, interacts with and is regulated at the t

156 This is the first report of TA receptor function in a native tissue and indicates unexp

157 g down-regulation of cardiac beta-adrenergic receptor function in chronic hypoxia.

158 y, we investigate the effect of loss of P2X7 receptor function on retinal structure and function duri

159 riched for DC-lineage cells expressing Notch receptors further validates the human thymus as a DC-poi

160 peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR) are members of the secretin-like class B

161 rsification of structurally distinct antigen receptor genes evolved independently in jawless and jawe

162 The glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR) are m

163 notably by stimulation of G protein-coupled receptors (GPCR).

164 tin-like class B family of G-protein-coupled receptors (GPCRs) and have opposing physiological roles

165 Family A G protein-coupled receptors (GPCRs) control diverse biological processes a

166 croarray analyses revealed G-protein-coupled receptor (GPR) signaling as a prominent EVI1 effector me

167 atty acids can activate the pro-inflammatory receptor GPR84 but so also can molecules related to 3,3'

168 Blockade of muscarinic receptors had no effect on evoked dopamine release, sugg

169 IN ABSCISSION (IDA)-derived peptide and its receptors, HAESA (HAE) and HAESA-LIKE2 (HSL2).

170 together, these findings show that the sigma receptor has a key role in METH dysregulation of dopamin

171 Fibroblast growth factor (Fgf) receptors have a recognized role in mammary ductal devel

172 r relevant insulin-like growth factor type 1 receptor (IGF-1R).

173 Insulin-like growth factor type 2 (IGF2) receptor (IGF2R) recognizes mannose 6-phosphate-containi

174 redicted best when both N-methyl-D-aspartate receptor-IgG and aquaporin-4-IgG coexisted (71%).

175 gical inhibition or gene ablation of the Ep3 receptor in mice suppresses accumulation of Ly6C(low) Mo

176 mulation of JNK also inactivates dopamine D2 receptors in a PRDX6-dependent manner.

177 ptic terminals where they signal via ErbB3/4 receptors in paracrine or juxtacrine mode.

178 brain in vivo, here applied to noradrenaline receptors in rat brain.

179 ) in rodents and selectively binds to TrkB/C receptors in vivo, as evidenced by entrectinib blocking

180 /mTOR pathway mediates signals from multiple receptors including insulin receptors, pathogen-associat

181 inetics revealed downregulation of select P2 receptors, including P2Y2R, in slow-growing hCPCs compar

182 part of a heterodimer with 14 other nuclear receptors, including the peroxisome proliferator-activat

183 We further uncover that several P2X receptors, including those able to desensitize, are perm

184 re we report a physiologically relevant NMDA-receptor-independent mechanism that drives increased AMP

185 s to demonstrate that metabotropic glutamate receptor-induced sensitization of TRPA1 nociceptors stim

186 ork by which activating mutations in the FGF receptor inhibit bone growth.

187 ucing the constitutive activities of odorant receptors, inhibiting the basal spike firing in olfactor

188 of IFN-regulatory factors (DAI) that contain receptor-interacting protein (RIP) homotypic interaction

189 Adaptor proteins such as receptor-interacting serine/threonine-protein kinase 1 (

190 g serine/threonine-protein kinase 1 (RIPK1), receptor-interacting serine/threonine-protein kinase 3 (

191 order to mimic properly IgGs Fc domain/FcRn receptor interaction.

192 n-like (MLKL) protein, which is triggered by receptor-interactive protein kinases (RIPK) 1 and 3.

193 activation of the heavily glycosylated Notch receptor involved in normal and malignant development.

194 n analogs with affinity for both the insulin receptor (IR) and mannose receptor C-type 1 (MR), which

195 One such nuclear receptor is DAF-12, which is required for normal nematod

196 ll behavior are coordinated through a single receptor is not known.

197 c fringe (Lfng), a key modifier of the Notch receptor, is selectively expressed in NSCs.

198 as a RALF-regulated scaffold that modulates receptor kinase complex assembly.

199 viding a first glimpse of what an active TAM receptor kinase may look like and suggesting a potential

200 -dependent binding of the activating NK cell receptor KIR2DS1, providing new insights into the underl

201 ocannabinoid activation of cannabinoid (CB1) receptors known to inhibit presynaptic GABA release was

202 nd murine forms of the myeloid C-type lectin receptor langerin for simple and complex ligands augment

203 B-453 cells, a model of the luminal androgen receptor (LAR) subtype of TNBC.

204 ng via antagonism of the autoinducer-binding receptors, LasR and RhlR.

205 an interaction between Xist RNA and Lamin B receptor (LBR) is necessary and sufficient for Xist spre

206 hod" for the biochemical characterization of receptor-ligand interactions.

207 sin-(1-7) by ACE2 and its binding to the Mas receptor (MasR) improves glucose homeostasis, partly by

208 r mitral cells (MCs) in the MOB where 5-HT2A receptors mediate a direct excitatory action.

209 EAAC1 limits group I metabotropic glutamate receptor (mGluRI) activation, facilitates D1 dopamine re

210 family of light-gated metabotropic glutamate receptors (mGluRs).

211 matrices and its interaction with a natural receptor molecule has tremendous importance in cell sign

212 Finally, we evaluated the capacity of anti-receptor monoclonal antibodies to deliver vaccine compon

213 physical exercise on the cerebral mu-opioid receptors (MOR) of 22 healthy recreationally active male

214 Mu opioid receptors (MORs) are central to pain control, drug rewar

215 ions provide a mechanistic link between EPHB receptor mutations and metastasis in colorectal cancer.

216 characterization of nicotinic acetylcholine receptor (nAChR) structure and function and have potenti

217 The mitophagy receptor Nix interacts with LC3/GABARAP proteins, target

218 had been considered mediated by neurokinin-1 receptor (NK-1R), we sought to determine whether itch in

219 CE STATEMENT Memantine and ketamine are NMDA receptor (NMDAR) channel-blocking drugs with divergent c

220 The activation of the N-methyl D-aspartate receptor (NMDAR) is controlled by a glutamate-binding si

221 NMDA receptors (NMDARs) are ionotropic glutamate receptors th

222 to show that activation of the transmembrane receptor NOTCH1 directly regulates vascular barrier func

223 co-stimulatory receptor B7.2 (CD86) as a co-receptor of lymphotropic HCV.

224 Sequence analysis of T-cell receptors of CD8(+) T cells revealed the presence of H-2

225 IsdB is a receptor on the surface of the bacterial pathogen Staphy

226 Chemoreception, mediated by the odorant receptors on the membrane of olfactory sensory neurons,

227 spects of JH function apparently require one receptor or the other.

228 mbrane domain of CD4, the asialoglycoprotein receptor, or the transferrin receptor eliminates intrame

229 To phenotype OT-receptor (OTR) expressing neurons originating within the

230 of systemic or centrally administered orexin receptor (OXR) antagonists on measures of impulsive-like

231 by targeting proregenerative P2Y2 nucleotide receptor (P2Y2R) activated by extracellular ATP and UTP

232 ls from multiple receptors including insulin receptors, pathogen-associated molecular pattern recepto

233 should be applicable to resolving many other receptor-pathway interactions.

234 y in humans for the highly selective sigma-1 receptor PET agent (18)F-6-(3-fluoropropyl)-3-(2-(azepan

235 The B7-CD28 family of ligands and receptors play important roles in T-cell co-stimulation

236 in mice led to sustained expansion of IL-33 receptor-positive kidney ILC2s and ameliorated adriamyci

237 f the nonselective cation channel, transient receptor potential canonical channel 6 (Trpc6), in isola

238 luding the peroxisome proliferator-activated receptors (PPARs).

239 binding of all investigated products to the receptor presented on cells with a similar potency (pEC5

240 ic and phenotypic analyses of FCGR3A/CD16 Fc-receptor profiles were compared in CAV-positive (n=52) a

241 No differences were detected in estrogen receptor, progesterone receptor, beta-catenin, or viment

242 tated 231 G521R ER cells despite appropriate receptor protein expression and nuclear localization.

243 ects selection for proper folding of the TCR receptor protein.

244 al. reveal a role for parathyroid hormone 2 receptor (PTH2R) in extracellular matrix production in w

245 Thus, alternate strategies that target receptor-receptor interactions are needed.

246 pendent mechanism that drives increased AMPA receptor recycling and LTP.

247 Receptors relevant to CNS disorders typically have assoc

248 e is hypomethylation of the aryl hydrocarbon-receptor repressor (AHRR) locus, which is observed in bl

249 e potential of sphingosine 1-phosphate (S1P) receptor (S1PR) agonism in the treatment of infectious d

250 owed subnanomolar affinity and excellent KOP receptor selectivity acting as full or partial agonists,

251 ovel mode of regulation of G protein-coupled receptor signaling by scaffolding proteins.

252 Dysregulation of tumor necrosis factor (TNF) receptor signaling is a key feature of various inflammat

253 ndergo the peroxisome proliferator-activated receptor signaling-dependent switch from glycolysis to f

254 including potassium channel function and EPH receptor signaling.

255 thors show that MRAP2 also regulates ghrelin receptor signalling in the hypothalamus and starvation s

256 Both the preprotein MTSs and their receptor site on SecA are essential for protein secretio

257 generate A2AR embedded phospholiposomes from receptor solubilized in n-dodecyl-beta-d-maltoside analo

258 ation of the three-dimensional structure and receptor specificity of the H15 hemagglutinin, revealing

259 that designing compounds to target specific receptor states, rather than specific receptor types, ma

260 sion of the key downstream messenger insulin receptor substrate-1 phosphorylated at serine residue 31

261 alue of 233 nM, selectivity versus other P2Y receptor subtypes, and is thought to act as an allosteri

262 Among the different existing receptor subtypes, the homomeric alpha7 nAChR has attrac

263 n implicated in interactions with the CD3 co-receptor, suggests a possible role for an allosteric mec

264 Many receptor systems, notably including growth factor recept

265 by exponential enrichment with a single AMPA receptor target (i.e. GluA1/2R) to isolate RNA aptamers

266 ults suggest the potential of using a single receptor target to develop RNA aptamers with dual activi

267 = 22); 44.4% received prior potent androgen receptor-targeted therapy.

268 d the bronchodilatory effect of bitter taste receptor (TAS2R) agonists in various models.

269 The interaction between the T cell antigen receptor (TCR) expressed by natural killer T cells (NKT

270 titis B virus-specific (HBV-specific) T cell receptor (TCR) may supplement HBV-specific immune respon

271 Defects in T cell receptor (TCR) repertoire are proposed to predispose to

272 is facilitated by peroxins including PEX5, a receptor that delivers cargo proteins from the cytosol t

273 ainst the alpha subunit of the interleukin-5 receptor that significantly reduces the incidence of ast

274 receptors (NMDARs) are ionotropic glutamate receptors that are crucial for neuronal development and

275 Synthetic receptors that are likewise capable of multi-stimuli res

276 of endothelial cells (EC) upregulates VCAM-1 receptors that target monocyte recruitment to atherosusc

277 ors that are ligands for the tyrosine kinase receptor, Tie2.

278 Toll-like receptors (TLRs) are innate immune receptors for sensing

279 The retention of intracellular Toll-like receptors (TLRs) in the endoplasmic reticulum prevents t

280 thway modulators and inhibitors of Toll-like receptors (TLRs).

281 , we conclude that nucleotides activate P2Y6 receptors to suppress GC growth through a novel SOCE/Ca(

282 R neurons recruit both GABA and GABA-A receptors to their axon terminals in the EB, and optogen

283 ure, we demonstrate that hRetn binds the LPS receptor Toll-like receptor 4 (TLR4) through its N termi

284 ase independently of epidermal growth factor receptor transactivation.

285 ties of recombinant alpha1beta2gamma2L GABAA receptors transiently expressed in HEK293T cells.

286 Thyroid hormone (TH) and TH receptors (TRs) alpha and beta act by binding to TH resp

287 ecific receptor states, rather than specific receptor types, may be a viable strategy for future drug

288 Epidermal growth factor receptor tyrosine kinase inhibitors, including gefitinib

289 a key regulator of not only GPCRs, but also receptor tyrosine kinases, including the highly cancer r

290 din-2 expression in colon and that bile salt receptors VDR and Takeda G-protein coupled receptor5 (TG

291 Recently, we found that vitamin D receptor (VDR) enhanced Claudin-2 expression in colon an

292 ing of a transcription factor, the vitamin D receptor (VDR), whose activating ligand vitamin D has be

293 lymphangiogenesis through signaling via VEGF receptor (VEGFR)-2 and VEGFR-3, respectively.

294 ical for synchrony in the adult SCN, and its receptor, VPAC2R, reached detectable levels after birth

295 A tetrapodal receptor was synthesized and was processed into fluoresc

296 inflammatory cytokines and various toll-like receptors were overexpressed in SAH neutrophils compared

297 Desensitization of nicotinic receptors, which is a prevailing mechanism for use-depen

298 The A2A receptor with a cytochrome b562-RIL (BRIL) fusion (A2AR-

299 ane domain of CD74 or the asialoglycoprotein receptor with Astn2 TM2 leads to the appearance of a car

300 Conversely, receptors with the intracellular domain of IR display hi